CD4 and COVID-19: After 20 days of hospitalization, with clinical improvements, all patients had increased CD4 T cells and lymphocytes (p < 0.05; Figures 2G–I), which may have been caused by the antiretroviral therapy for HIV or immune activity in COVID-19 (Dessie et al., 2020).